Published in Clin Exp Immunol on July 01, 1980
T lymphocyte subsets in inflammatory bowel disease: peripheral blood. Gut (1983) 1.57
Characteristics and function of Fc receptors on human lymphocytes. Immunology (1982) 1.09
Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome. Clin Exp Immunol (1982) 1.00
Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors. Clin Exp Immunol (1985) 0.98
Relationship between T cell subpopulations and the mitogen responsiveness and suppressor cell function of peripheral blood mononuclear cells in normal individuals. Clin Exp Immunol (1980) 0.93
Further characterization of lymphocytes from human colonic lamina propria: identification of TG cells. Clin Exp Immunol (1981) 0.93
Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease. Gut (1984) 0.92
The role of TG lymphocytes in cell-mediated immunity in patients with periodontal disease. Clin Exp Immunol (1981) 0.88
Enumeration of lymphocyte populations defined by surface markers in the whole blood of patients with Crohn's disease. Gut (1982) 0.85
Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine. Clin Exp Immunol (1982) 0.81
Spontaneous suppressor cell activity in the peripheral blood of patients with malignant and chronic inflammatory bowel diseases. Clin Exp Immunol (1984) 0.80
Loss of suppressor T-cells in active inflammatory bowel disease. Gut (1984) 0.80
Controlled therapeutic trial of levamisole and sulphasalazine in acute ulcerative colitis. Gut (1984) 0.75
Reference Values for a Panel of Cytokinergic and Regulatory Lymphocyte Subpopulations. Immune Netw (2016) 0.75
Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J (1955) 19.22
An extension of the 51Cr-release assay for the estimation of mouse cytotoxins. Transplantation (1968) 9.80
Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med (1977) 9.57
An improved rosetting assay for detection of human T lymphocytes. J Immunol Methods (1974) 6.54
Expression of a receptor for IgM by human T cells in vitro. Eur J Immunol (1975) 5.05
Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. J Immunol (1976) 4.64
The relation between regional ileitis and sarcoidosis. Lancet (1958) 3.29
Receptors for IgG molecules on human lymphocytes forming spontaneous rosettes with sheep red cells. Eur J Immunol (1975) 3.26
Short-term course and prognosis of Crohn's disease. Gut (1974) 2.90
Delayed hypersensitivity and lymphocyte transformation in Crohn's disease and proctocolitis. Gut (1969) 2.61
Fc-receptor heterogeneity of human suppressor T cells. J Immunol (1978) 2.37
Isolation and characterization of naturally occurring subclasses of human peripheral blood T cells with regulatory functions. J Immunol (1978) 2.30
Development of delayed hypersensitivity to dinitrochlorobenzene in patients with Crohn's disease. Gut (1969) 2.20
Immunological studies in ulcerative colitis. 3. Incidence of antibodies to colon-antigen in ulcerative colitis and other gastro-intestinal diseases. Clin Exp Immunol (1966) 2.11
Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 2.04
Peripheral blood T and B cells in chronic inflammatory bowel disease. Gastroenterology (1974) 1.97
Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells. J Clin Invest (1979) 1.87
Further animal evidence of a transmissible agent in Crohn's disease. Lancet (1973) 1.85
Peripheral blood and intestinal lymphocyte sub-populations in Crohn's disease. Gut (1975) 1.77
Morphologic and functional characteristics of human intestinal lymphoid cells isolated by a mechanical technique. Gastroenterology (1979) 1.73
Subpopulations of human T lymphocytes. I. Studies in immunodeficient patients. Clin Exp Immunol (1977) 1.69
Impaired anamnestic cellular immune response in patients with Crohn's disease. Gut (1975) 1.65
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
No evidence for decreased lymphocyte reactivity in Crohn's disease. Gastroenterology (1974) 1.49
The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes. J Clin Invest (1978) 1.49
Delayed hypersensitivity in regional enteritis and ulcerative colitis. Am J Dig Dis (1966) 1.48
The immune competence of patients with inflammatory bowel disease. Gut (1974) 1.43
Primary and secondary abnormalities of T cell subpopulations. Clin Exp Immunol (1978) 1.43
The subpopulations of circulating white blood cells in inflammatory bowel disease. Gastroenterology (1976) 1.41
Investigation of the pathogenic mechanisms in regional enteritis with in vitro lymphocyte cultures. Gastroenterology (1971) 1.40
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
Mixed-lymphocyte reaction as a measure of immunological competence of lymphocytes from patients with Crohn's disease. Gut (1974) 1.34
Serum lymphocytotoxic and lymphocytophilic antibody activity in inflammatory bowel disease. Gastroenterology (1974) 1.30
Inflammatory bowel disease: lymphocytic responses to nonspecific stimulation in vitro. Scand J Gastroenterol (1972) 1.26
A study of peripheral leucocyte migration in agarose medium in inflammatory bowel disease. Gut (1974) 1.23
Evidence of an agent transmissible from ulcerative colitis tissue. Lancet (1976) 1.16
Lymphocyte transformation and delayed hypersensitivity in Crohn's disease. Scand J Gastroenterol (1972) 1.10
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07
The E-rosette assay: a cautionary note. Clin Immunol Immunopathol (1979) 1.06
Immunological studies in patients with Crohn's disease. Gut (1976) 1.03
Alteration of T-lymphocyte subpopulations in sarcoidosis. Clin Immunol Immunopathol (1978) 1.03
In vitro testing of immunoresponsiveness in patients with inflammatory bowel disease: prevalence and relationship to disease activity immunoresponsiveness in IBD. Clin Exp Immunol (1979) 0.91
Immune status in Crohn's disease. 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes. Gut (1979) 0.91
Impaired lymphocyte reactivity against tumour cells in patients with Crohn's disease. Gut (1972) 0.84
Clinical significance of white bile in the biliary tree. Gut (1969) 0.84
Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis. The Abacus Investigator Group. Gastroenterology (1998) 3.90
Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology (1997) 3.68
Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg (1984) 2.78
Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest (1982) 2.48
Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease. Gastroenterology (1983) 2.37
Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury. Gut (1997) 2.35
Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet (1990) 2.22
Specialist investigation of obscure gastrointestinal bleeding. Gut (1987) 2.10
Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 2.04
Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology (1986) 2.03
Indium-111 autologous leucocyte scanning: comparison with radiology for imaging the colon in inflammatory bowel disease. Br Med J (Clin Res Ed) (1982) 1.96
111Indium autologous leucocytes in inflammatory bowel disease. Gut (1983) 1.95
Coma after cardiac arrest. Brain (1974) 1.86
Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest (1982) 1.84
Observations on the reflex response to muscle vibration in man and its voluntary control. Brain (1969) 1.78
Decreased suppressor cell activity in inflammatory bowel disease. Clin Exp Immunol (1978) 1.75
Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation. Lancet (1986) 1.66
Alteration in suppressor cell activity in chronic active hepatitis. Proc Natl Acad Sci U S A (1978) 1.57
Immune-complex mediated colitis in rabbits. An experimental model. Gut (1978) 1.54
Chronic immune colitis in rabbits. Gut (1979) 1.46
Differing acute phase responses in Crohn's disease and ulcerative colitis. Gut (1986) 1.44
Portal vein thrombosis in myeloproliferative disease. Uses of thrombolytic and antiplatelet treatment. BMJ (1990) 1.43
Pleural involvement in the carcinoid syndrome. Q J Med (1993) 1.42
Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease. Gut (1985) 1.35
C3 metabolism in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 1.34
Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet (1984) 1.34
Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth. Hepatogastroenterology (1989) 1.25
Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut (1992) 1.25
Atopic disorders and adult coeliac disease. Lancet (1976) 1.20
Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist. Br Med J (Clin Res Ed) (1987) 1.20
Assessment of disease activity in inflammatory bowel disease: a new approach using 111In granulocyte scanning. Br Med J (Clin Res Ed) (1983) 1.16
The ineffectiveness of excitation of the primary endings of the muscle spindle by vibration as a respiratory stimulant in the decerebrate cat. J Physiol (1968) 1.14
In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver (1997) 1.13
Animal models of acute hepatic failure. Int J Exp Pathol (2000) 1.10
The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10. J Immunol (2001) 1.09
111Indium autologous granulocytes in the detection of inflammatory bowel disease. Gut (1985) 1.09
Hepatocyte growth factor/scatter factor expression in human mammary epithelium. Am J Pathol (1994) 1.07
Why measure C reactive protein? Gut (1994) 1.07
Campylobacter pylori, duodenal ulcer disease, and gastrin. BMJ (1989) 1.06
Humoral immune system in inflammatory bowel disease: I. Complement levels. Gut (1977) 1.05
Role of hepatic arterial embolisation in the carcinoid syndrome. Br Med J (Clin Res Ed) (1983) 1.05
Jaundice associated with naproxen. Postgrad Med J (1980) 1.05
Spontaneous suppressor cell function in inflammatory bowel disease. Dig Dis Sci (1981) 1.04
Human serum does contain a high molecular weight hepatocyte growth factor: studies pre- and post-hepatic resection. Biochem Biophys Res Commun (1986) 1.04
Comparison of the frequency of interleukin (IL)-2-, interferon-gamma-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. J Infect Dis (2001) 1.03
Lymphocyte reactivity to ex-vivo drug antigens in drug-induced hepatitis. J Hepatol (1994) 1.02
Effects of nonsteroidal anti-inflammatory drugs and misoprostol on gastroduodenal epithelial proliferation in arthritis. Gastroenterology (1992) 1.01
Vascular anomalies of the gastrointestinal tract. Hepatogastroenterology (1984) 1.00
Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome. Clin Exp Immunol (1982) 1.00
Dimethyl sulphoxide induces a reduced growth rate, altered cell morphology and increased epidermal-growth-factor binding in Hep G2 cells. Biochem J (1991) 0.99
Treatment of haemobilia by selective arterial embolisation. Gut (1980) 0.99
Chronic liver disease due to hepatitis C. BMJ (1993) 0.98
Plasma lactoferrin and neutrophil elastase in rheumatoid arthritis and systemic lupus erythematosus. Br J Rheumatol (1990) 0.98
Are there ethnic differences in inflammatory bowel disease? Indian J Gastroenterol (1986) 0.97
The effect of adrenaline on the response to muscle vibration in man. J Physiol (1969) 0.97
Fluticasone propionate in Crohn's disease. Gut (1991) 0.96
Malabsorption and macroamylasemia. Response to gluten withdrawal. Am J Med (1980) 0.96
MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab Brain Dis (1996) 0.96
Familial autonomic visceral myopathy with degeneration of muscularis mucosae. J Clin Pathol (1988) 0.95
Faecal elastase reflects disease activity in active ulcerative colitis. Scand J Gastroenterol (1992) 0.95
Is the pattern of inflammatory bowel disease different in the elderly? Age Ageing (1985) 0.95
Transplanted isolated hepatocytes: effect of partial hepatectomy on proliferation of long-term syngeneic implants in rat spleen. Pathology (1987) 0.94
Enteral therapy in the management of massive gut resection complicated by chronic fluid and electrolyte depletion. Dig Dis Sci (1982) 0.94
Further characterisation of 'hepatotropin', a high molecular weight hepatotrophic factor in rat serum. J Hepatol (1989) 0.94
Enhanced in vitro and in vivo gene delivery using cationic agent complexed retrovirus vectors. Gene Ther (1998) 0.94
Granulocyte migration in ulcerative colitis. Eur J Clin Invest (1985) 0.94
Assessment of drug therapy in inflammatory bowel disease. Br J Clin Pharmacol (1982) 0.93
Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection. J Immunol (1999) 0.93
Whipple's disease with unusual clinical, bacteriologic, and immunologic findings. Gastroenterology (1986) 0.93
Relationship between T cell subpopulations and the mitogen responsiveness and suppressor cell function of peripheral blood mononuclear cells in normal individuals. Clin Exp Immunol (1980) 0.93
Marked immunosuppressive effects of the HIV-2 envelope protein in spite of the lower HIV-2 pathogenicity. AIDS (2000) 0.92
Augmentation of the early phase of liver regeneration after 70% partial hepatectomy in rats following selective Kupffer cell depletion. J Hepatol (1998) 0.92
Specificity of indium-111 granulocyte scanning and fecal excretion measurement in inflammatory bowel disease--an autoradiographic study. Dig Dis Sci (1985) 0.91
Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery. Clin Exp Immunol (1999) 0.91
Malignant histiocytosis and encephalomyeloradiculopathy complicating coeliac disease. Gut (1983) 0.90
Role of cell adhesion molecules in leukocyte recruitment in the liver and gut. Int J Exp Pathol (2003) 0.90
Visualising E-selectin in the detection and evaluation of inflammatory bowel disease. Gut (1998) 0.90
Review article: the immunoregulatory cytokine interleukin-10--a therapy for Crohn's disease? Aliment Pharmacol Ther (2001) 0.89
A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours. Hum Gene Ther (1999) 0.88
The growth of transplanted liver cells within the pancreas. Transplantation (1988) 0.88
Cirrhosis in South London. Lancet (1976) 0.88
T-helper cross reactivity to viral recombinant proteins in HIV-2-infected patients. AIDS (1993) 0.88
Carcinoid syndrome. Medical management. Br J Hosp Med (1986) 0.88
Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol (1995) 0.87
Resistance of three immortalized human hepatocyte cell lines to acetaminophen and N-acetyl-p-benzoquinoneimine toxicity. J Hepatol (1999) 0.87
IgA in alcoholic cirrhosis. Clin Exp Immunol (1983) 0.87
Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver (1999) 0.87
Whipple's disease complicated by a retinal Jarisch-Herxheimer reaction: a case report. Gut (1992) 0.87
Circulating human leucocyte elastase in rheumatoid arthritis. Rheumatol Int (1986) 0.87
Corticosteroids reduce regenerative repair of epithelium in experimental gastric ulcers. Gut (1995) 0.87
Indium-111 whole-body retention: a method for quantification of disease activity in inflammatory bowel disease. J Nucl Med (1992) 0.87
The pulmonary vascular bed as a site for implantation of isolated liver cells in inbred rats. Transplantation (1984) 0.86
The humoral immune system in inflammatory bowel disease. II. Immunologlobulin levels. Am J Dig Dis (1978) 0.86
T-helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected individuals. J Med Virol (1995) 0.86